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Abstract 
We have previously shown that the glucocorticoid receptor (GR) is required for skin 
homeostasis and epidermal barrier competence. To understand the transcriptional program by 
which GR regulates skin development, we performed a microarray analysis using the skin of 
E18.5 GR-/- and GR+/+ mouse embryos and identified 442 differentially expressed genes. 
Functional clustering demonstrated overrepresentation of genes involved in ectoderm/epidermis 
development. We found strong repression of genes encoding proteins associated with the later 
stages of epidermal differentiation, such as several small proline-rich proteins (Sprrs) and 
corneodesmosin (Cdsn). This, together with the upregulation of genes induced earlier during 
epidermal development, including the epithelial-specific gene transcripts E74-like factor 5 
(Elf5) and keratin 77 (Krt77), fits with the phenotype of defective epidermal differentiation 
observed in the GR-/- mice. We also found downregulation of the antimicrobial peptide defensin 
beta 1 (Defb1) and FK506 binding protein 51 (Fkbp51). Skin developmental expression 
profiling of these genes and studies in cultured keratinocytes from GR-/- and wt embryos 
demonstrated that gene regulation occurred in a cell-autonomous manner. 
 To investigate the consequences of GR loss in adult epidermis, we generated mice with 
inducible inactivation of GR restricted to keratinocytes (K14-cre-ERT2//GRloxP/loxP mice). K14-
cre-ERT2//GRloxP/loxP mice featured thickened skin with increased keratinocyte proliferation and 
impaired differentiation. While Krt77 and Elf5 expression remained unaffected by loss of GR in 
adult epidermis, Fkbp51, Sprr2d and Defb1 were strongly repressed. Importantly, we have 
identified both Fkbp51 and Defb1 as direct transcriptional targets of GR and we have shown 
that GR mediated regulation of these genes occurs in both developing and adult epidermis. We 
conclude that both overlapping and differential GR targets are regulated in developing vs. adult 
skin. 
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Introduction  
The glucocorticoid receptor (GR) is a 
ubiquitous intracellular protein that belongs 
to the superfamily of steroid nuclear 
receptors and functions as a ligand-
dependent transcription factor. Upon 
binding to glucocorticoid (GC) ligand, GR 
dissociates from cytoplasmic complexes, 
dimerizes and translocates to the nucleus, 
where it can modulate gene transcription in 
a cell type-specific manner (reviewed in 1). 
The determinants that achieve the gene- and 
cell type-specificity of GR transcriptional 
regulation are not well established. In fact, 
transcriptomic approaches have found little 
overlap in GC-regulated genes between 
different cell types (2, 3). GR can also 
regulate gene expression through DNA-
binding-independent mechanisms that 
involve its interference with other 
transcription factors, such as NF-κB or AP-
1 (4). In addition, GR has non-genomic 
actions that involve physical interaction of 
the receptor at the plasma membrane with 
p85α/PI3K, thus modulating AKT activity 
(5). 
Given its pleiotropic actions in 
many vital organs, GR is required for 
survival and also plays a crucial role in skin 
pathophysiology (6, 7). GC derivatives are 
the most widely used therapeutic agents for 
treating numerous cutaneous diseases (8). 
However, GR is also required for proper 
skin development, as shown by 
complementary approaches of genetically 
modified mice with gain- and loss-of-
function of GR (9-12). In mammals, the 
skin acts as a barrier between the individual 
and the environment. Proper acquisition of 
a functional skin barrier during embryonic 
development requires a correct balance 
between proliferation, differentiation and 
controlled apoptosis of epidermal 
keratinocytes (reviewed in 13). Impairment 
of these processes can cause skin disorders 
of keratinization and cornification, the 
consequences of which range from post 
natal lethality to increased susceptibility to 
cutaneous infections and development of 
inflammatory skin diseases (14-16). 
The epidermis is a stratified 
epithelium consisting of a basal layer 
formed by proliferative keratinocytes and 
several upper layers in which keratinocytes 
become progressively more differentiated 
as they migrate outwards (13). During 
mouse epidermal development upon 
commitment to terminal differentiation, 
genes expressed by basal keratinocytes, 
such as keratin K5, are repressed and 
differentiation specific proteins, including 
keratins K1 and K10 are upregulated. 
Epidermal terminal differentiation 
represents a specialized form of 
programmed cell death, in which viable 
keratinocytes convert into dead, flattened 
squames of the stratum corneum. These 
processes need to be tightly coordinated to 
form a competent epidermal barrier in vivo; 
however, the underlying transcriptional 
program is not completely understood (15). 
It is known, however, that the calcium 
gradient of the mammalian epidermis, with 
low levels in the basal/intermediate layers 
and high levels in the upper layers, 
modulates the expression of differentiation-
specific proteins (17, 18). We recently 
demonstrated that GR-/- late embryos 
(E18.5) feature incomplete epidermal 
stratification and impaired keratinocyte 
differentiation, resulting in a defective skin 
barrier (12). The use of cultured mouse 
primary keratinocytes (MPKs) from GR-/- 
mice demonstrated that GR regulates 
keratinocyte growth and apoptosis in a cell-
autonomous manner. However, although 
epidermal differentiation was severely 
impaired in vivo, cultured MPKs from GR-
deficient mice were able to differentiate in 
the presence of high calcium, a well 
established model of in vitro keratinocyte 
differentiation (19). These results suggest 
that GR-/- skin might display a defective 
calcium gradient that can be overcome in 
cell culture by adding calcium. 
Alternatively, cultured GR-/- keratinocytes 
could be able to differentiate due to growth 
factors and hormones present in the culture 
medium that are lacking in the GR-/- 
embryonic skin in vivo. 
Previous reports identified putative 
GR transcriptional targets in keratinocytes 
by indirect approaches that evaluated the 
effects of the synthetic ligand 
dexamethasone (Dex) in vitro or in wild 
type (wt) embryos that were exposed to 
pharmacological doses of the corticosteroid 
during development (20, 21). In this work, 
we have analyzed the transcriptional profile 
of GR-/- embryonic skin using a microarray 
approach in order to identify GR 
transcriptional targets in vivo that are 
relevant for epidermal morphogenesis. 
Given the perinatal lethality of the 
GR-/- mice and to further investigate the 
role of GR specifically in adult 
keratinocytes in vivo, we have generated an 
inducible conditional knock-out mouse 
model, the K14-cre-ERT2//GRloxP/loxP mice. 
This model allows us to distinguish the 
consequences of the loss of GR in 
epidermal keratinocytes from those of the 
complete knockout and demonstrate that 
GR is not only required for normal 
epidermal development but also for adult 
skin homeostasis. Additionally, our analysis 
of gene expression suggests that GR 
regulates common and differential gene 
subsets in embryonic and adult skin. 
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Results 
To understand the mechanisms by which 
GR regulates skin development, we 
performed a transcriptomic analysis using 
the skin of GR-/- mouse embryos (E18.5) as 
compared to wt littermates. We found 442 
differentially expressed genes (DEGs) in 
GR-/- vs GR+/+ skin (FDR<0.05); of these, 
206 were repressed and 236 were induced 
(see Supplementary Table 1 for the 
complete list). DEGs were grouped by 
functional clustering according to the Gene 
Ontology category of biological process 
(Supp. Fig. 1). Although genes were 
categorized based on protein function, 
many genes likely fit into more than one 
category. Consistent with the previously 
described phenotype of GR-/- mice, with 
impaired keratinocyte terminal 
differentiation and defective epidermal 
development (12), the functional category 
of ectoderm/epidermis development was 
overrepresented in the microarray analysis 
(4.6%) (Supp. Fig. 1 and Supp. Table 2). 
We performed quantitative RT-PCR to 
validate the microarray results and found a 
very good correlation for the genes tested 
(Fig. 1). Among these genes, we found 
several components of the cornified 
envelope that were strongly repressed, 
including the small proline-rich protein 
(Sprr) gene family members Sprr1b, Sprr2d 
and Sprr2h as well as corneodesmosin 
(Cdsn) (Fig. 1 and Supp. Table 2; fold-
change: 0.06, 0.09, 0.13, 0.36; 
respectively). It is worth noting, that 
expression of the components of the 
epidermal cornified envelope has been 
previously correlated with barrier initiation 
(reviewed in 22), which is defective in GR-/- 
skin (12). We detected the expression of 
keratin 12 (Krt12) mRNA in developing 
epidermis in contrast to previous reports of 
expression restricted to cornea epithelium 
(23). We also found dowregulation of 
FK506 binding protein 51 (Fkbp51), 
growth factor independent 1 (Gfi1), 
prostaglandin-endoperoxide synthase 1 
(Ptgs1) and beta defensin 1 (Defb1). In 
addition, we found a modest but consistent 
upregulation of epidermal growth factor 
receptor (Egfr), a key player in epithelial 
development (24), as well as B-cell 
leukemia/lymphoma 6 (Bcl6), an immediate 
early gene that is activated in lymphocytes 
but whose expression has also been 
described in keratinocytes (25). Notably, 
the highest upregulated genes were two 
epithelial-specific gene transcripts: E74-like 
factor 5 (Elf5) and the keratin 77 (Krt77) 
(26, 27). 
Our analysis of the transcriptional 
profile of GR-/- developing skin has 
identified genes previously unknown as 
GR-regulated in keratinocytes such as 
Sprr2d, Krt12, Defb1, Egfr, Krt77 and Elf5. 
We have also detected other genes, 
including Cdsn, Ptgs1, Bcl6 and Fkbp51, 
which were previously reported to be 
affected by Dex treatment in keratinocytes 
(20, 21, 28). We confirmed transcript 
changes at the protein level for CDSN, 
PTGS1, BCL6 and ELF5, by 
immunohistochemistry in GR-/- embryonic 
skin using specific antibodies (Fig. 1B). 
These proteins are normally detected in the 
cornified envelope (CDSN) and upper 
layers of the developing skin (PTGS1, 
BCL6) and have been previously reported 
to be involved in keratinocyte 
differentiation (29, 30, 25). ELF5 
expression in skin is controversial since 
some reports describe Elf5 expression in 
mouse epidermis and oral keratinocyte cell 
lines (26; 31) whereas others describe Elf5 
exclusively in the inner root sheath of the 
hair follicle (32). To better understand the 
contribution of the identified genes in 
epidermal development, we focused on a 
subset of the novel GR-targets, using the 
previously described Dex-regulated genes 
as a control of transcriptional regulation 
mediated by GR in vivo. We analyzed the 
expression of Cdsn, Sprr2d, Defb1, Krt77, 
Elf5 and Bcl6 in the skin of wt developing 
embryos and newborn mice by quantitative 
RT-PCR using at least four individuals of 
each age (E14.5-P0, Fig. 2A). Cdsn mRNA 
levels were undetectable at E14.5 but 
induced at E16.5 and E18.5. Sprr2d 
transcripts were upregulated at E18.5, and 
further upregulated at P0. These data are in 
agreement with the reported role of these 
genes in late epidermal differentiation (22). 
In contrast, Krt77, Elf5 and Bcl6 mRNA 
levels peaked at E16.5 and were 
subsequently repressed at E18.5 and P0 
(Fig. 2A). Defb1 transcript levels were 
induced at E16.5 and remained at similar 
levels at P0. The fact that Krt77, Elf5 and 
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Bcl6 are expressed with relatively high 
levels in normal developing epidermis at 
E16.5, when the epidermis is still immature 
(Fig. 2A), suggests that these genes are part 
of the transcriptional program of epidermal 
maturation at early stages. Their subsequent 
repression suggests that has to be reduced 
for the proper completion of differentiation. 
Importantly, the observed changes in these 
GR-regulated genes paralleled the mRNA 
expression of Nr3c1 (the GR-encoding 
gene) during skin development (Fig. 2A). 
To evaluate gene expression 
changes during differentiation, we isolated 
and cultured MPKs from wt embryos 
(E18.5) and treated them with media 
containing high concentrations of calcium 
(1.2 mM). After calcium exposure, we 
detected characteristic changes in cell 
morphology including cell flattening and 
increased cell-cell contacts (Fig. 2B, upper 
panel). We analyzed the changes in gene 
expression at 24h and 48h after calcium 
treatment and found, as expected, that the 
differentiation-associated markers Cdsn and 
Sprr2d were markedly upregulated at 24h 
(Fig. 2B, 8- to 11-fold increase, 
respectively). After 48h of high calcium 
exposure, and in agreement with their 
observed mRNA expression pattern in wt 
developing skin (Fig. 2A), Cdsn returned to 
basal levels whereas Sprr2d transcription 
was further increased (Fig. 2B, 1.4- to 12-
fold increase, respectively). We also found 
strongly increased Defb1 transcript levels 
that peaked at 24h and calcium-induction of 
Elf5 and Bcl6, although to a lesser extent 
(2- to 4-fold increase) and with delayed 
kinetics. In contrast, Krt77 mRNA was 
repressed by high calcium in cultured 
keratinocytes (Fig. 2B), which is in 
agreement with the observed repression of 
this gene in late wt embryos (Fig. 2A).  
Since the lack of GR has an impact 
on the expression of the identified genes 
(Fig. 1), we took the complementary 
approach to study the consequences of 
ligand-activation of the GR in a time-course 
experiment using wt MPKs (Fig. 2C). Dex 
(100 nM) elicited morphological features of 
differentiation of cultured keratinocytes at 
24h, as shown in Fig. 2C, upper panel and 
previous reports (12). Dex treatment 
upregulated Cdsn, Sprr2d, Defb1 and 
Fkbp51 in cultured MPKs, in agreement 
with their repression in GR null skin (Fig. 
2C, middle panel). However, Bcl6 
induction after Dex treatment was not 
consistent with its upregulation in GR-/- 
skin. The observed kinetics of Dex 
induction for Cdsn, Sprr2d and Bcl6 were 
late (24h) and for Defb1 and Fkbp51, early 
and sustained (3-24h). In contrast, Krt77 
and Elf5 were repressed by Dex at 3-6h (2- 
to 4-fold) in a transient manner, consistent 
with the upregulation observed in GR-/- skin 
(Fig. 2C, lower panel). Although the 
expression of many of the identified genes 
is restricted to keratinocytes, such as Cdsn, 
Sprr1b, Sprr2d, Sprr2h, Edar, Egfr, Krt77 
and Elf5, other genes were expressed in cell 
types besides epithelia, as with Defb1, Bcl6 
and Fkbp51. The changes we observed in 
vivo might be keratinocyte-autonomous or 
due to dermal contribution. To ascertain 
this, we cultured GR-/- and wt MPKs in 
media with normal serum and evaluated 
gene expression (Fig. 3A). The differences 
in the transcript levels of Cdsn, Defb1, 
Krt77, Elf5, Bcl6 and Fkbp51 between GR-/- 
and wt MPKs grown in normal serum-
containing media were consistent with 
those found in the microarray and 
validation experiments (Fig. 3A). It is also 
possible that other hormones and growth 
factors, including corticosterone, contribute 
in some way to the transcriptional profile of 
the developing skin. To assess this, GR-/- 
and wt MPKs were grown in media with 
steroid-depleted serum and gene expression 
was evaluated in the presence and absence 
of treatment with Dex (Fig. 3B). Notably, 
when MPKs isolated from GR KO mice 
were cultured in steroid-depleted serum, 
Krt77 and Elf5 were not upregulated, thus 
suggesting that additional hormones and 
growth factors in the medium are relevant 
for the basal expression levels of these 
genes (Fig. 3B). However, most 
importantly, all of the genes we analyzed in 
GR-/- MPKs treated with Dex showed either 
no response or marginal changes as 
compared to wt (Fig. 3B and data not 
shown). These data demonstrate that GR is 
required for transcriptional regulation of the 
identified genes in a keratinocyte-specific 
manner. 
We further investigated whether the 
identified genes are regulated through GR 
activity by evaluating the effects of the GR 
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antagonist RU486 in combination with Dex 
in cultured keratinocytes (Fig. 3C and D). 
Although the genes regulated by Dex with 
early kinetics are more likely to be primary 
GR-transcriptional targets, we analyzed the 
expression of both early (Krt77, Elf5, 
Fkbp51) and late (Cdsn, Sprr2d) genes. In 
the case of Defb1, Dex induced mRNA 
expression at 3h and 24h (Fig. 2C). For all 
of the tested genes, RU486 was able to 
reverse the effects of Dex, regardless of 
whether the ligand-activated GR induced or 
repressed gene expression (Fig. 3C and D). 
These data suggest that gene regulation is 
primarily due to GR activity. In order to 
differentiate direct GR-transcriptional 
targets from those regulated via other GR-
controlled proteins, we used the inhibitor of 
protein synthesis cycloheximide (CHX) to 
check the mRNA levels of Defb1, Fkbp51, 
Krt77 and Elf5, which are regulated by Dex 
with early kinetics (Fig. 4A). We observed 
that Defb1 and Fkbp51 show a robust 
induction in the presence of Dex plus CHX, 
indicating that their regulation is due to 
GR-mediated transcriptional activation 
(Fig. 4A). In the case of Krt77 and Elf5, 
both genes were still repressed in the 
presence of Dex plus CHX (Fig. 4A). To 
discriminate whether these genes were 
regulated via direct binding of GR to their 
regulatory elements, we performed ChIP 
assays using wt MPKs treated with vehicle 
or Dex (Fig. 4B). We first examined 
Fkbp51 since the Dex-dependent binding of 
the GR at an Fkbp51 enhancer has been 
previously demonstrated in other cell types 
(So et al., 2007). For these experiments, 
given that Fkbp51 mRNA induction was 
detected at 3h upon Dex treatment (Fig.2C, 
3B and 3C), we evaluated GR binding after 
2h of incubation with Dex (Fig. 4). Our 
data show that GR was recruited to the 
Fkbp51 enhancer exclusively after ligand-
activation of GR in cultured keratinocytes.  
It has been demonstrated that most 
of the GR binding sites (GBS) in a natural 
gene context are represented by non-
conventional GC response elements (GRE) 
and/or composite elements (3, 33, 34). We 
first searched for predicted GBS in 
conserved regions proximal to genes of 
interest using Alibaba 2.1. We then 
compared the conservation of putative GBS 
between human and mouse, since it has 
been reported that, for GC-induced genes, 
conservancy is a good predictor of GR 
binding (33). Using this strategy, we found 
putative GBS with high degrees of 
conservacy between mouse and human in 
the proximal promoter of Krt77 and the first 
intron of Elf5. However we were unable to 
detect binding of the GR to these regions in 
ChIP assays (Fig. 4). Neither the upstream 
region nor the introns of the Defb1 gene are 
conserved between human and mouse, 
nevertheless, we searched for putative GBS 
in its proximal promoter and found two 
putative GR half sites, with the sequence 
AGAACA. We detected GR bound to the 
Defb1 proximal promoter in Dex-treated vs 
untreated wt MPKs, as shown by ChIP 
assays (Fig. 4). These data suggest that in 
the presence of ligand, GR may 
transactivate Defb1 by its recruitment to a 
GBS half-site. 
Studies of the role of GR in gene 
regulation and homeostasis in adult skin 
were not feasible due to the perinatal death 
of GR-/- mice. Therefore, we generated mice 
with an inducible conditional inactivation 
of GR restricted to keratinocytes. This 
model also allowed us to compare the 
consequences of GR inactivation restricted 
to the epidermis to that of the complete 
knockout. We crossed mice with both gr 
alleles floxed (GRloxP/loxP, 35) with mice 
expressing a Cre recombinase-ER fusion 
protein under the control of the 
keratinocyte-specific keratin 14 promoter 
(K14-cre-ERT2, 36) (Fig. 5A). To induce 
activation of Cre, the resulting progeny, 
K14-cre-ERT2//GRloxP/loxP and 0-cre-
ERT2//GRloxP/loxP littermates were treated 
with tamoxifen (TAM) at 8-wks of age 
(37). Recombination was tested in the 
epidermis and dermis from tail biopsies by 
PCR (Fig. 5B). Our data demonstrate that 
Cre-mediated recombination was 
specifically detected in the epidermis of 
TAM treated K14-cre-ERT2//GRloxP/loxP and 
not 0-cre-ERT2//GRloxP/loxP mice, as shown 
by the appearance of the null band (390 bp), 
whereas recombination did not occur in the 
dermis (Fig. 5B). Accordingly, we only 
detected loss of the GR protein in the 
epidermis of TAM treated K14-cre-
ERT2//GRloxP/loxP mice, as shown by 
immunoblotting (Fig. 5C). 
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We analyzed the skin phenotype of 
TAM treated K14-cre-ERT2//GRloxP/loxP mice 
in comparison with 0-cre-ERT2//GRloxP/loxP 
littermates (Fig. 6A) by hematoxylin/eosin 
(H&E) staining. Adult skin with 
keratinocyte-restricted GR loss-of-function 
was characterized by thickened epidermis 
and a marked dermal infiltrate (Fig. 6A, 
H&E). These findings demonstrate that GR 
is not only required for normal epidermal 
development but also for adult skin 
homeostasis, even in non-pathological 
conditions. A more detailed 
immunohistochemical analysis 
demonstrated that several markers of 
epidermal proliferation and differentiation 
had alterations in their expression and/or 
localization (Fig. 6A). The expression of 
keratin K6, normally restricted to the hair 
follicle, was upregulated in the 
interfollicular epidermis of the conditional 
GR knock-out, a feature suggestive of 
hyperproliferation (11). In addition, the 
expression of the early marker of epidermal 
differentiation K10 was confined to the 
most suprabasal layer of the epidermis of 
K14-cre-ERT2//GRloxP/loxP mice instead of 
being localized throughout all suprabasal 
layers. The expression of loricrin and 
CDSN, both markers of late epidermal 
differentiation, was reduced in K14-cre-
ERT2//GRloxP/loxP, with a “patchy” 
appearance. To quantitate proliferation in 
K14-cre-ERT2//GRloxP/loxP mice, we analyzed 
BrdU incorporation in adult epidermis that 
was either untreated or treated with the 
phorbol ester PMA for 48h (Fig. 6B). This 
acute treatment is known to induce 
hyperproliferation and inflammation when 
applied topically (11). The average basal 
rate of epidermal proliferation in adult skin 
is 2% and we found a statistically 
significant increase of around 3-fold in 
mice with GR inactivation in keratinocytes 
(Fig. 6B). In addition, the proliferative 
response to PMA was more pronounced in 
K14-cre-ERT2//GRloxP/loxP as compared to 
control littermates (about 2-fold). Overall, 
our findings underline the key role of GR in 
the adult to inhibit keratinocyte 
proliferation both in basal and stress 
conditions. 
Since the histopathology of K14-
cre-ERT2//GRloxP/loxP skin demonstrated 
impaired proliferation and differentiation, 
we checked whether this phenotype 
correlated with the dysregulation of genes 
identified in our microarray study. 
Quantitative RT-PCR assays using the 
epidermis of adult transgenic and non-
transgenic tail biopsies showed that Sprr2d, 
Defb1 and Fkbp51 mRNA levels were 
strongly repressed in mice with GR 
inactivation restricted to keratinocytes, 
indicating that GR regulates several genes 
in embryonic and adult skin in a similar 
manner (Fig. 6C). In addition, our data 
demonstrate that the expression of these 
genes is specifically due to GR function in 
keratinocytes. However, neither Krt77 nor 
Elf5 transcripts exhibited statistically 
significant changes in adult epidermis with 
specific ablation of GR (Fig. 6C), 
suggesting that GR modulates these genes 
exclusively during epidermal development.
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Discussion 
Skin barrier function has to be complete at 
the time of birth in order to preserve 
mammals from changes in body 
temperature, dehydration and entrance of 
microorganisms (14, 15). Recently, we 
demonstrated that GR is required during 
embryonic development for correct 
epidermal stratification and formation of a 
competent skin barrier (12). In the present 
work, we aimed to investigate whether an 
altered transcriptional program may 
underlie the defects in GR-/- skin. Our 
microarray analysis has identified, among 
others, the dysregulation of genes that 
belong to the functional category of 
ectoderm/epidermis development. In the 
developing GR-/- skin, we found strong 
downregulation of some of the major 
constituents of the cornified envelope 
(Sprr1b, Sprr2d, Sprr2h and Cdsn), as well 
as repression of genes involved in 
epidermal terminal differentiation (Ptgs1 
and Bcl6). We also detected a modest but 
consistent upregulation of several genes 
that are key players in epithelial 
development, such as Egfr, ectodysplasin-A 
receptor (Edar) and forkhead box N1 
(Foxn1) (Supp. Table 2 and Fig.1; 1.2-, 1.2- 
and 1.5-fold, respectively). The highest 
upregulated genes in the GR-deficient skin 
were Krt77 and the epithelial-specific 
transcription factor Elf5 (23- and 11-fold, 
respectively). Both genes are expressed at 
relatively high levels during earlier stages 
(E16.5) and downregulated in later stages 
of epidermal development (Fig. 2A). Our 
findings are in agreement with previous 
reports indicating that Krt77 mRNA is 
abruptly induced at embryonic day E15.5 
and exclusively localized in the developing 
suprabasal layers of the epidermis (27). Elf5 
and Bcl6 were also transiently upregulated 
at E16.5 and their mRNA levels declined 
thereafter (Fig. 2A). The fact that Elf5 and 
Bcl6 were inhibited at later stages in 
differentiating skin yet upregulated by high 
calcium in cultured keratinocytes (Fig. 2A 
and B) is most likely due to the limitations 
of this in vitro model for keratinocyte 
differentiation, which is unable to fully 
recapitulate the physiological 
circumstances. Moreover, this model only 
accounts for the differentiation of the 
interfollicular epidermis, but not for other 
epidermal compartments such as sebaceous 
glands and hair follicles. This may explain 
the apparent discrepancies of Elf5 and 
possibly Bcl6 gene expression in vivo 
versus in vitro. 
It is known that Elf5 is also 
expressed in other epithelial cells, and has a 
prominent role in mammary gland and lung 
morphogenesis (38, 39). Given that GR also 
plays key roles in the development of both 
tissues (6), it can not be ruled out that ELF5 
acts as a mediator of GR signaling in other 
epithelia besides epidermis. In addition, 
both Krt77 and Elf5 have glandular 
expression (40, 41). The fact that some of 
the identified genes are expressed in other 
stratified epithelia deriving from the 
embryonic ectoderm is in agreement with 
the phenotype reported in ectodermal 
derivatives of two GR gain-of function 
transgenic mouse models (10, 11). In this 
regard, our data showing Krt12 mRNA in 
the developing epidermis instead of 
exclusively restricted to cornea epithelium 
(23) indicates a wider and developmentally-
regulated expression pattern of this keratin. 
In a previous report that analyzed 
the transcriptomic profile of cultured 
human keratinocytes in response to Dex, 
the authors proposed that GCs may have a 
dual effect on epidermal differentiation by 
promoting the late stages of terminal 
differentiation while simultaneously, 
inhibiting the early stages (20). The authors 
reported that Dex upregulates genes 
involved in stratum corneum formation, 
such as transglutaminase 1, filaggrin and 
Cdsn. Their results fit with the opposite 
regulation of these genes that we detect in 
vivo in GR-/- skin. The augmented 
expression of Krt77, Elf5 and Bcl6 in GR 
null skin (Fig. 1) can be explained either by 
the lack of inhibition of early markers of 
keratinocyte differentiation and/or reflect a 
delay in epidermal development of these 
mice, since these transcripts peak at early 
embryonic stages (E15.5-E16.5). However, 
given our observations of regulation of 
Krt77 and Elf5 by Dex in vitro, a lack of 
GR-mediated inhibition of these markers 
likely contributes to their overexpression in 
the GR-/- keratinocytes. 
A study by Patel and colleagues 
reported that exposure of wt early embryos 
(E15.5) to Dex in utero accelerated 
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epidermal barrier formation by 
approximately 12h relative to untreated 
embryos (21). It was described that the 
transcriptional profile of Dex-treated skin 
was significantly changed only at this 
timepoint, when the skin is still immature, 
and not in subsequent developmental 
stages. Based on these data, the authors 
postulated that GC actions seem to be 
crucial for epidermal barrier acquisition in a 
critical developmental window (E15 to 
E15.5), prior to the observed accelerated 
barrier formation (21). In contrast, we have 
detected transcriptional changes in GR-/- 
embryonic skin at E18.5, suggesting a 
broader “field of competence” of GR 
action. Several of the genes described as 
corticosteroid-regulated in E15.5 Dex-
treated embryos are coincident with genes 
identified in our microarray and are 
regulated in an opposite manner relative to 
GR-deficient skin. These genes include the 
keratinocyte differentiation markers Cdsn 
and Ptgs1 and the inflammatory cytokine 
Il-18 (Fig.1 and Supp. Table 1). However, 
many other genes identified by Patel et al. 
do not overlap with our data set. The 
different transcriptomic signatures may be 
explained by the diverse experimental 
settings, including the embryo 
developmental stage (E18.5 vs E15.5) 
and/or the complete ablation of GR vs the 
use of pharmacological doses of GCs. The 
advantage of our analysis of the 
transcriptional profile of GR-/- developing 
skin is that it provides a relevant biological 
setting to identify GR transcriptional targets 
in vivo. In fact, this analysis has allowed us 
to unveil genes previously unknown as GR-
regulated in keratinocytes. 
There are several mouse models 
with impaired barrier formation showing an 
aberrant expression of epidermal 
differentiation markers, including members 
of the SPRR family, K1, loricrin, filaggrin, 
involucrin, repetin and the transcriptional 
regulator Krüppel-like factor 4 (KLF4) 
(22). Although we found that the mRNA 
levels of loricrin, filaggrin, involucrin and 
repetin, components of the so-called 
epidermal differentiation complex, were 
reduced in GR-/- skin with statistical 
significance (fold-change: 0.7, 0.22, 0.49, 
0.048, respectively; p<0.01), these genes 
were excluded from our list with a more 
restrictive cutoff (FDR<0.05). 
The histological evaluation of GR 
null skin did not show a phenotype 
compatible with a chronic inflammatory 
state and, accordingly, the genes of 
inflammatory and immune responses were 
not overrepresented in our data set (Supp. 
Table 1). The cytokine IL18 has been 
shown to play a role in human keratinocyte 
survival (42), which is in agreement with its 
strong repression in GR null skin, which 
has increased keratinocyte apoptosis (12). 
Defb1, a gene related to the innate immune 
response and epithelial defense was also 
repressed in GR-/- skin. This contrasts with 
other mouse models with defective 
epidermal barriers, including knock-out 
mice for the gene-encoding transcription 
factors Gata-3 and Klf4, in which the innate 
immune response was activated by up-
regulation of different antimicrobial 
peptides (Defb1 in the Gata-3 null and 
Defb-3 and -6 in the Klf4 null), most likely 
as a compensatory mechanism (43). 
Besides its role in the innate immune skin 
response, it was shown that overexpression 
of Defb1 in vitro promotes terminal 
differentiation of a keratinocyte cell line 
(44). The decreased Defb1 mRNA 
expression and reduced terminal 
differentiation observed in the embryonic 
GR-/- and the adult K14-cre-ERT2//GRloxP/loxP 
skin suggest that this gene may also play a 
role in keratinocyte differentiation in vivo. 
Recently, it has been postulated that the 
loss of human Defb1 function contributes to 
the malignant progression of oral squamous 
cell carcinoma (45). While human Defb1 
was shown to be induced by Dex in airway 
epithelial cultures (46), to our knowledge 
this gene has not been shown to be 
regulated by GR in keratinocytes. Similarly, 
Fkbp51 is known as a classical GR-target in 
other cell types (3) and described as the 
highest upregulated gene in follicular stem 
cells of adult transgenic K5-GR mice (28). 
However, it was not previously reported as 
a direct GR transcriptional target in 
keratinocytes (Fig. 4). Our findings that 
Defb1 and Fkbp51 are regulated by GR in 
GR-/- embryonic skin and adult epidermis of 
K14-cre-ERT2//GRloxP/loxP (Fig. 1 and 5) and 
that they are primary GR transcriptional 
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targets (Fig. 4) are suggestive of an 
important role in the skin. 
It was recently shown that most 
GBS in the natural gene context are 
represented by non-conventional GRE sites 
and/or composite elements that are 
distributed evenly through the genomic 
DNA (3, 31, 32). In A549 cells, the 
majority of GBS (63%) were found to be 
more than 10kb distal from transcriptional 
start sites (31). This explains the difficulty 
of identifying GR transcriptional targets by 
conventional approaches searching for 
consensus GBS sequences in proximal 
promoters. In addition, the low overlap of 
GC-regulated genes among different cell 
types found by transcriptomic approaches 
further supports that the contribution of 
cell-type specific transcription factors and 
coregulators is crucial to modulate GR-
mediated transcription. It has been reported 
that for GC-induced genes, conservation of 
a GRE sequence among species is a good 
predictor of GR binding (3). We first 
searched for putative GBS in gene 
sequences that were highly conserved 
between human and mouse. Our search 
retrieved no putative conserved GBS in the 
first intron of Defb1. However, we 
observed the Dex-dependent binding of GR 
to a sequence in the Defb1 proximal 
promoter (-1 kb) that contained two GRE 
half-sites (Fig. 4). These results suggest that 
ligand-bound GR can transactivate Defb1 
by its recruitment to a GRE half-site, 
without requiring dimerization-dependent 
DNA-binding of the receptor. The presence 
of AP-1 and Sp-1 sites near the GRE 
hexameric sequences suggests that the 
binding of GR is mediated through a 
composite element (data not shown). In this 
context, the fact that GR-/- skin, but not 
GRdim/dim, featured abnormal skin 
architecture (12) must be reinterpreted 
considering that, as previously 
demonstrated, several genes can be 
transcriptionally regulated in the GRdim/dim 
mice through direct binding of GR 
monomers to DNA (47-49). 
We also assessed whether GR 
bound to Krt77 and Elf5 gene regulatory 
sequences by ChIP assays (Fig. 4). For 
these experiments, we used sequences 
highly conserved between human and 
mouse (Krt77, 8/10 nucleotide 
conservancy; Elf5, 10/10 nucleotide 
conservancy). We could not detect GR 
binding to either of these sites, likely 
because these genes are GR repressed and 
thus, the rule of nucleotide conservation 
does not apply. However, it can not be 
ruled out that GR binds to other genomic 
sequences and/or that it transcriptionally 
regulates these genes through 
transrepression mechanisms that do not 
require the binding of the receptor to DNA. 
In fact, Krt77 and Elf5 have predicted AP-1 
sites located within the 1 kb region 
upstream of their transcriptional start sites 
(data not shown). 
A major point of this study is the 
demonstration that GR is not only required 
for embryonic epidermal development but 
also for adult skin homeostasis, as shown 
by the increased keratinocyte proliferation 
and impaired differentiation of TAM-
treated K14-cre-ERT2//GRloxP/loxP mice in 
comparison with 0-cre-ERT2//GRloxP/loxP 
littermates (Fig. 5C, D). When we checked 
whether this adult skin phenotype 
correlated with the altered transcriptional 
profile identified in our microarray analysis 
using GR-deficient embryos, we found 
similar repression of Sprr2d, Defb1 and 
Fkbp51 transcripts; however, Krt77 and 
Elf5 transcripts were GR-regulated 
exclusively in developing skin (Fig. 5E). 
The adult skin of K14-cre-ERT2//GRloxP/loxP 
mice showed increased dermal 
inflammation with numerous 
polimorphonuclear cells, which stained 
positive for an anti-Ly6G antibody (data 
not shown). Our data indicate that GR plays 
different roles in developing vs adult skin. 
Impaired epidermal barrier function 
can underlie inflammatory skin diseases 
such as psoriasis and atopic dermatitis, and 
topical GCs are one of the main treatments 
for these disorders (15, 16). Given the 
crucial role of GR in epidermal barrier 
function and skin homeostasis, we set out to 
determine its transcriptional targets in the 
skin during development. Our results show 
that many of the genes regulated by GR 
during skin development are similarly 
controlled in the adult tissue. Therefore, the 
data from this study will be useful for 
future research on the effects of GC 
treatment in normal and diseased adult skin. 
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Materials and methods 
Animal experimentation and treatments 
GR-/-, GRloxP/loxP and K14-Cre-ERT2 mice 
have been previously reported (6, 33, 34). 
Genotyping of the transgenic colonies was 
performed using DNA isolated from mouse 
tail biopsies and analyzed by PCR, as 
described 12, 35). GR-/- and GR+/+ embryo 
littermates (n=36) were obtained by 
cesarean derivation at 18.5 days post-
conception (the morning of the day that the 
vaginal plug was seen was considered as 
day 0.5). For the microarray analysis, we 
analyzed 4 embryo dorsal skin samples of 
each genotype and 6 additional skin 
samples were independently collected for 
the validation by quantitative RT-PCR. We 
also analyzed 22 skin samples from WT 
E16.5, E18.5 and P0 mice. K14-cre-
ERT2//GRloxP/loxP male mice were crossed 
with 0-cre-ERT2//GRloxP/loxP females and the 
resulting adult progeny were used for the 
experiments (n=32). Dorsal skin was 
excised and either rapidly frozen in liquid 
nitrogen to isolate RNA and protein, fixed 
for immunohistochemistry or processed for 
preparation of mouse primary keratinocytes 
(MPKs) as described below. 
Mice were housed in standard 
temperature and humidity conditions and 
animal experimentation was conducted with 
accepted standards of humane animal care 
in our animal facility (Instituto de 
Biomedicina de Valencia IBV-CSIC). 
Experiments were performed in accordance 
with the current Spanish and European 
normative which governs research with 
animals (Real Decreto 1201/2005, B.O.E. 
#252, 10 of October, 2005 and Convenio 
Europeo 1-2-3 del 18/3/1986). 
Phorbol 12-myristate 13-acetate 
(PMA, Sigma, St. Louis, MO) was applied 
topically as a single dose of 8 μg/mouse for 
48h. For tamoxifen (TAM)-induced 
recombination, K14-cre-ERT2//GRloxP/loxP 
and 0-cre-ERT2//GRloxP/loxP adult mice (8-
wks) were i.p. injected with 0.2 mg TAM 
diluted in corn oil (C8267, Sigma; 100 
μl/mouse) daily for five consecutive days. 
10 days after the last injection, 
recombination was tested in tail epidermis 
biopsies by PCR using specific primers 
(35). 
 
RNA isolation and Microarray analysis 
Total RNA was isolated from dorsal skin of 
mice of the indicated genotypes and 
corresponding control littermates (at least, 
four animals of each genotype) or from 
cultured keratinocytes (at least, three 
replicates were used per experimental 
group) using Trizol reagent (Invitrogen, 
Molecular Probes, Eugene, Oregon), 
following manufacturer´s 
recommendations. The differential 
transcriptomic profile of GR-/- vs GR+/+ 
E18.5 skin was analyzed using four 
microarrays (Affymetrix GeneChip® 
Mouse Genome 430 2.0) per genotype. 
RNA was purified by standard procedures 
(Qiagen, Valencia, CA) and its integrity 
tested by the Bioanalyzer 2100 (Agilent 
Technologies). Microarray hybridization, 
data normalization and analysis were 
carried on the genomic platform at the 
Centro de Investigación del Cáncer de 
Salamanca, as described on their webpage 
(http://ubioinfo.cicancer.org). The quality 
control for microarray hybridization 
includes an estimation of the signal 
detected for each probeset using the 
algorithm RMA (Robust Microarray 
Analysis), performed in three steps: (i) 
background correction, (ii) quantile 
normalization and (iii) summarized 
estimation by probeset. The values resulting 
from this algorithm are read as absolute 
expression values in a logarithmic scale 
(log2). To estimate the DEGs with 
statistically significant value between 
control and transgenic samples, the 
algoritm SAM (Significance Analysis of 
Microarrays) was used. SAM is a modified 
test of differential contrast that includes the 
discrimination of the p-values by 
permutations and has an adjusted p-value 
by multiple tests using the False Discovery 
Rate or FDR (50). The FDR cutoff uses the 
delta value (d) of the algoritm. Each delta is 
associated to a given FDR and a number of 
significant genes 
(http://ubioinfo.cicancer.org). The gene list 
with the 442 DEGs with statistical 
significance (FDR<0.5) in GR-/- vs GR+/+ is 
in Supp. Table 1. Functional clustering was 
performed according to the Gene Ontology 
(GO) category: biological process using the 
tool set Babelomics v.3.1 
(http://www.babelomics.org/) (Supp. Fig.1). 
Genes that belong to the functional 
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category ectoderm/epidermis development 
appear in Supp. Table 2. 
 
Quantitative RT-PCR 
1 μg of total RNA was reverse transcribed 
by using oligo-dT (Fermentas Inc., 
Burlington, Canada) followed by 
quantitative PCR using specific 
oligonucleotides for each of the genes 
tested and FastStart Universal SYBR Green 
Master ROX (Roche) in an Applied 
Biosystems 7500 Fast real time PCR 
system. Oligonucleotide sequences are in 
Supp. Table 3. At least three biological 
replicates were used for each experimental 
group (mouse skin or cultured 
keratinocytes) and technical triplicates were 
assessed to calculate the mean value ± SD. 
Statistical significance was calculated using 
the Student’s t test, p < 0.05.  
 
Antibodies 
Polyclonal antibodies to GR (sc-1004, 
Santa Cruz, CA) and an antibody specific 
for actin (A-2066, Sigma Chemical Co., St. 
Louis, MO) were used for immunoblotting. 
Secondary peroxidase-conjugated anti-
rabbit antibody was from Amersham 
(Aylesbury, UK) and secondary peroxidase-
conjugated anti-mouse antibody was from 
Jackson ImmunoResearch (Jackson 
ImmunoResearch Laboratories, Inc. West 
Grove, PA). 
For imunohistochemistry, we used 
anti-BCL6 (sc-858) and anti-ELF5 (sc-
9645) from Santa Cruz, anti-PTGS1 
(160109) from Cayman Chemical (Ann 
Arbor, MI), and the monoclonal antibody 
F28-27 specific for CDSN (a gift from 
Serres´s lab, CNRS, 51). The anti-keratin 
K5 (PRB-160P), K6 (PRB-169P), K10 
(PRB-159P) and loricrin (PRB-145P) 
antibodies were from Covance (Babco, 
Berkeley, CA). Secondary biotin-
conjugated anti-rabbit or anti-mouse 
antibodies were from Jackson 
ImmunoResearch (Jackson 
ImmunoResearch Laboratories, Inc. West 
Grove, PA). 
 
Histological and Immunohistochemical 
analysis 
Skin samples were fixed in 4% 
paraformaldehyde (PFA) or 70% ethanol 
and embedded in paraffin. Consecutive 4 
μm-thick sections were obtained. For 
histopathology, sections were stained with 
H&E. Prior to immunostaining, paraffin 
sections were dewaxed and microwaved in 
10 mM citrate solution. For 
immunohistochemistry, paraffin sections 
were blocked with 5% fetal bovine serum, 
and then incubated with the primary 
antibody for at least one hour. Slides were 
washed three times with PBS, and then 
incubated with conjugated secondary 
antibodies for 1 h. The reaction was 
visualized with the Avidin-Biotin-Complex 
(ABC) kit from DAKO (Vectastain Elite, 
Vector Laboratories, Inc, Burlingame, CA) 
using diamino-benzidine as chromogenic 
substrate for peroxidase. Slides were 
mounted and analyzed by light microscopy 
(Leica DM RXA2), and images were taken 
at 40x magnification.  
 
In vivo epidermal BrdU labeling 
Epithelial cell proliferation was measured 
by i.p. injection of BrdU (130  μg/g of body 
weight, Roche) 1 h before sacrifice. BrdU 
incorporation was detected by 
immunohistochemistry of paraffin-
embedded sections using a mouse anti-
BrdU monoclonal antibody (biotest, 
Roche). The number of BrdU-positive cells 
and the number of total cells was 
determined per 200 μm of interfollicular 
epithelium in each section. Experiments 
were performed at least in five individuals 
of each genotype and statistical significance 
was assessed by using the Student’s t test, 
(p < 0.05).  
 
MPK isolation, culture and treatments 
Skin of E18.5 embryos was incubated in 
0.25% trypsin at 4ºC overnight. The 
epidermis was separated from the dermis, 
minced and homogenized in complete low 
calcium medium. The filtered solution 
contained MPKs, which were collected by 
centrifugation. MPKs were pooled (two 
mice of each genotype) and 106 cells were 
plated into one 35 mm diameter collagen I-
coated tissue culture dish (BD Biosciences) 
and cultured at 37ºC in standard medium. 
After 24 h, the medium was replaced with 
low calcium medium and cells were grown 
until subconfluency. The composition of 
standard medium was: Essential modified 
Eagle´s medium EMEM (BioWhitakker, 
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Inc., Walkersville, MD), supplemented with 
4% fetal calf serum (FCS, BioWhitakker, 
Inc.) plus 0.6 mM CaCl2 and antibiotics. To 
prepare low-calcium medium, FCS was 
depleted of divalent cations by treatment 
with Chelex deionizing resin (BioRad, 
Hempstead, UK) and supplemented with 
CaCl2 to a final concentration of 0.05 mM. 
EGF (Sigma, St. Louis, MO) (10 ng/ml) 
and antibiotics were added to growth 
medium. 
To assess in vitro differentiation, 
equal numbers of MPKs were plated and 
grown to confluency under low calcium 
(0.05 mM) conditions and then shifted to 
high calcium (1.2 mM) for 24 h or 48 h.  
Dexamethasone (Dex, Sigma, St. 
Louis, MO, 100 nM), RU486 (BIOMOL 
Research Laboratories, Inc., Plymouth 
Meeting, PA, 1 μM), cycloheximide (CHX, 
Sigma, 2.5 μg/ml) or vehicle was added for 
the indicated times to confluent wt MPKs 
that had been incubated in charcoal-stripped 
serum overnight to deplete steroid 
hormones. 
 
Immunoblotting 
Whole cell extracts (20 µg) were prepared 
as previously described (12), boiled in 
Laemmli buffer and separated on 10% 
sodium dodecyl sulfate-polyacrylamide 
gels (SDS-PAGE), then transferred to 
nitrocellulose filters (Hybond ECL, 
Amersham, Aylesbury, UK). The 
membranes were stained with Ponceau S 
(Sigma Chemical Co., St. Louis, MO) to 
verify equal protein loading and transfer. 
Filters were blocked with 5% nonfat dry 
milk in PBS-0.1% Tween 20 at 4º C 
overnight, washed three times in PBS-0.1% 
Tween 20 and incubated with the indicated 
antibodies. After washing, membranes 
were incubated with a peroxidase-
conjugated secondary antibody 
(Amersham), washed again, and analyzed 
using the enhanced chemiluminiscence 
method (ECL, Amersham), according to 
manufacturer’s recommendations. 
Experiments were performed in at least 
three individuals of each genotype. 
 
Chromatin immunoprecipitations 
Chromatin immunoprecipitations (ChIP) 
were performed using the ChIP assay kit 
from Millipore (Billerica, MA) following 
manufacturer’s instructions, with slight 
modifications. MPKs were seeded at a 
density of 750,000 cells per 35 mm dish 
and grown to approximately 85% 
confluency in low calcium medium, as 
indicated above. Following overnight 
incubation in low calcium medium 
containing charcoal-stripped serum, cells 
were treated in the presence or absence of 
Dex (100 nM) for 2 h. Keratinocytes were 
cross-linked by incubation with 1% 
formaldehyde for 10 minutes at RT. 
Chromatin shearing was performed in 
Eppendorf tubes using a Bioruptor 
sonicator (Diagenode, Liege, Belgium) set 
to HI for 12 minutes with 30 second 
ON/OFF cycles. Sonicated chromatin was 
immunoprecipitated with 2 μg of either 
rabbit IgG (Sigma) or rabbit anti-GR (sc-
1004; Santa Cruz Biotechnology). 
Following ChIP, reversion of cross-linking, 
and treatment with proteinase K and RNase, 
DNA was purified using a DNA clean up 
spin kit (Genomed, Löhne, Germany). PCR 
was performed with primers specific for 
regions containing putative GBS (Supp. 
Table 4). 
Alibaba 2.1 was used to search for 
putative GBS http://www.gene-
regulation.com/pub/programs.html#alibaba
2). Conservation between species was 
assessed using the Vista Genome Browser 
(http://genome.lbl.gov/vista/index.shtml). 
The primers used for ChIP assays were 
designed using Primer BLAST 
(http://www.ncbi.nlm.nih.gov/tools/primer-
blast/). 
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Figure legends  
Fig. 1. Differential transcriptomic profile of E18.5 GR-/- embryonic skin compared to wild-type 
(WT) littermates 
A) Relative mRNA levels of a subset of DEGs in GR-/- vs wt skin as determined by microarray 
analysis (quadruplicate skin samples of each genotype) and quantitative (Q)-PCR validation in 
an independent experiment with at least three individuals of each genotype. Fold changes 
(relative to WT) in the array vs QPCR are shown. Standard deviations for QPCR data are shown 
as well as p-values calculated using the Student’s t-test. B) Protein expression of CDSN, PTGS1 
BCL6 and ELF5 was demonstrated in paraffin-embedded dorsal skin of GR-/- and WT E18.5 
littermates by immunostaining using specific antibodies. Bars: 50 μm. 
Fig. 2. Expression of DEGs during in vivo and in vitro keratinocyte differentiation 
A) Gene expression of Nr3c1 and the indicated DEGs during skin development in E14.5, E16.5, 
E18.5 and newborn (P0) wt mice. B) Kinetics of gene expression during keratinocyte 
differentiation induced by treatment of wt mouse primary keratinocytes (MPKs) with high 
calcium (1.2 mM). Cell differentiation was assessed by phase contrast (upper panels) and 
expression of the indicated genes determined by QPCR. C) Kinetics of gene expression during 
keratinocyte differentiation induced by treating wt MPKs with either vehicle (-) or Dex (100 
nM). Cell differentiation was assessed by phase contrast (upper panels) and gene expression 
determined by QPCR. Experiments were performed using at least three culture replicates for 
each treatment and timepoint. Statistically significant differences were assessed by Student´s t-
test (*, p<0.005; **, p<0.001). 
Fig. 3. Gene regulation of relevant DEGs in cultured MPKs isolated from GR-/- skin and 
responses to GR agonist and antagonists 
A-B) GR-/- and wt MPKs isolated from E18.5 embryonic skin were cultured in either serum-
containing media (A) or steroid-depleted serum (B) and gene expression was determined by 
QPCR. In addition, Dex response at 3h was evaluated in GR-/- and wt MPKs (B). Note the 
drastically reduced response to Dex of GR-/- MPKs relative to wt controls. C-D) Effects of the 
GR antagonist RU486 in combination with Dex in cultured keratinocytes at 3h (C) and 24h (D). 
Note that RU486 reverses the effects of Dex on induced and repressed genes. Experiments were 
performed using at least three culture replicates for each genotype and treatment; and statistical 
significance was assessed by Student´s t-test (*, p<0.005; **, p<0.001). 
Fig. 4. Identification of Fkbp51 and Defb1 as primary GR target genes in keratinocytes 
 
A) Wt MPKs were cultured in the presence of vehicle (-), Dex (100 nM), CHX (2.5 μg/ml) or 
Dex plus CHX for 3h to assess gene expression of the indicated genes by QPCR (*, p<0.05; **, 
p<0.005; ***, p<0.0001). B) GR binding to the indicated genes was assessed by ChIP assays 
using wt MPKs treated with vehicle (-) or Dex (100 nM) for 2h. Chromatin was 
immunoprecipitated with either rabbit IgG (rIgG, 2 μg) or rabbit anti-GR antibody (2 μg) 
followed by PCR using primers specific for sequences that contained putative glucocorticoid 
binding sequences (GBS), as described in the text. GR bound to Fkbp51 and Defb1 but not 
Krt77 or Elf5 regulatory sequences. 
 
Fig. 5. Generation of mice with inducible GR loss-of-function restricted to adult keratinocytes 
(K14-cre-ERT2//GRloxP/loxP mice) 
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A) Scheme depicting the structure of K14-Cre-ERT2 and GRloxP/loxP transgenic lines. The K14-
Cre-ERT2 transgene contains the human K14 promoter, the rabbit β-globin intron, the Cre-
ERT2 coding sequence and the SV40 polyadenylation (polyA) signal. The GRloxP allele was 
generated by introducing two loxP sequences in the second and third introns. In the double 
transgenic K14-cre-ERT2//GRloxP/loxP mice treated with tamoxifen (TAM), the recombinase under 
the control of the K14 promoter deletes the DNA fragment flanked by the loxP sites, rendering a 
GRnull allele exclusively in keratinocytes. The size of the PCR products corresponding to the 
GRwt (225 bp), GRloxP (275 bp), and GRnull (390 bp) alleles is indicated at the right. B) K14-cre-
ERT2//GRloxP/loxP and 0-cre-ERT2//GRloxP/loxP adult mouse littermates were treated with TAM and 
keratinocyte-specific recombination was assessed in epidermis (E) and dermis (D) from tail 
biopsies. Recombination was exclusively detected in the epidermis of TAM-treated K14-cre-
ERT2//GRloxP/loxP and not 0-cre-ERT2//GRloxP/loxP mice. C) Immunoblotting using specific anti-GR 
antibody demonstrates the absence of GR protein specifically in the epidermis of K14-cre-
ERT2//GRloxP/loxP mice. Actin was used as a loading control. 
 
Fig. 6. Alterations in proliferation, differentiation and gene expression of K14-cre-
ERT2//GRloxP/loxP mice 
A) Impaired proliferation and differentiation of adult skin with keratinocyte-restricted GR 
inactivation. Hematoxylin/eosin (H&E) staining of adult K14-cre-ERT2//GRloxP/loxP mice showed 
thickened epidermis (bracket) and a marked dermal infiltrate (arrows). Immunostaining using 
specific antibodies against keratin 6 (K6), keratin 10 (K10), loricrin (LOR) and corneodesmosin 
(CDSN) shows abnormal epidermal proliferation and differentiation in the conditional knock-
out mice. Bars: 50 μm. B) Percentage of BrdU incorporation in adult interfollicular epidermis 
treated with vehicle or the phorbol ester PMA for 48h. C) Gene regulation in the absence of GR 
in adult keratinocytes was determined by QPCR using the epidermis of adult conditional 
knockouts and control tail biopsies. Coincidences and divergences in gene regulation due to the 
lack of GR were found in adult vs embryonic skin. Fkbp51, Sprr2d and Defb1 mRNA levels 
were strongly repressed in K14-cre-ERT2//GRloxP/loxP mice whereas no changes in Krt77 or Elf5 
transcripts were detected. Statistically significant differences were assessed by Student´s t-test 
(*, p<0.01; **, p<0.005). 
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